• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Results of induction and consolidation treatment with intermediate and high-dose ara-C and m-AMSA containing regimens in patients with primarily failed or relapsed acute leukemia and non-Hodgkin's lymphoma.

作者信息

Peters W G, Willemze R, Colly L P

出版信息

Scand J Haematol Suppl. 1986;44:7-16. doi: 10.1111/j.1600-0609.1986.tb01587.x.

DOI:10.1111/j.1600-0609.1986.tb01587.x
PMID:3515513
Abstract
摘要

相似文献

1
Results of induction and consolidation treatment with intermediate and high-dose ara-C and m-AMSA containing regimens in patients with primarily failed or relapsed acute leukemia and non-Hodgkin's lymphoma.采用含中高剂量阿糖胞苷及胺苯吖啶方案对初次诱导治疗失败或复发的急性白血病及非霍奇金淋巴瘤患者进行诱导和巩固治疗的结果。
Scand J Haematol Suppl. 1986;44:7-16. doi: 10.1111/j.1600-0609.1986.tb01587.x.
2
Intermediate and high-dose ARA-C and m-AMSA (or daunorubicin) as remission and consolidation treatment for patients with relapsed acute leukaemia and lymphoblastic non-Hodgkin lymphoma.中高剂量阿糖胞苷和米托蒽醌（或柔红霉素）用于复发急性白血病和淋巴细胞性非霍奇金淋巴瘤患者的缓解及巩固治疗。
Scand J Haematol. 1985 Jan;34(1):83-7. doi: 10.1111/j.1600-0609.1985.tb00748.x.
3
Intermediate-dose Ara-C/m-AMSA for remission induction and high-dose Ara-C/m-AMSA for intensive consolidation in relapsed and refractory adult acute myelogeneous leukemia.中等剂量阿糖胞苷/米托蒽醌用于复发和难治性成人急性髓性白血病的缓解诱导，高剂量阿糖胞苷/米托蒽醌用于强化巩固。
Haematol Blood Transfus. 1990;33:333-8. doi: 10.1007/978-3-642-74643-7_63.
4
Modulation of cytosine arabinoside (ara-C) and high-dose ara-C in acute leukemia.急性白血病中阿糖胞苷（ara-C）及大剂量阿糖胞苷的调控作用
Semin Oncol. 1985 Jun;12(2 Suppl 3):139-43.
5
[Clinical activity of m-Amsa and the combination of m-Amsa with cytosine arabinoside].[米托蒽醌的临床活性以及米托蒽醌与阿糖胞苷联合用药的临床活性]
Nouv Presse Med. 1982 Oct 9;11(39):2911-4.
6
[Treatment of acute myeloid leukemia with amsacrine and high-dose cytosine arabinoside: a phase II trial].用安吖啶和大剂量阿糖胞苷治疗急性髓细胞白血病：一项II期试验
Bull Cancer. 1985;72(1):37-41.
7
Intermediate-dose Ara-C/m-AMSA for remission induction and high-dose Ara-C/m-AMSA for intensive consolidation in relapsed and refractory adult acute myelogenous leukemia (AML).中等剂量阿糖胞苷/米托蒽醌用于复发和难治性成人急性髓性白血病（AML）的缓解诱导，高剂量阿糖胞苷/米托蒽醌用于强化巩固。
Anticancer Res. 1989 Jan-Feb;9(1):119-24.
8
[Combination of AMSA-high dose cytosine arabinoside in acute leukemia].
Presse Med. 1985 Jun 29;14(26):1417-20.
9
Amsacrine: a review.安吖啶：综述
Leuk Res. 1986;10(11):1257-65. doi: 10.1016/0145-2126(86)90331-0.
10
Current status of amsacrine (AMSA) combination chemotherapy programs in acute leukemia.安吖啶（AMSA）联合化疗方案在急性白血病中的现状
Cancer Treat Rep. 1983 Nov;67(11):967-70.

引用本文的文献

1
High-dose cytosine arabinoside: pharmacological and clinical aspects.大剂量阿糖胞苷：药理学及临床方面
Blut. 1988 Jan;56(1):1-11. doi: 10.1007/BF00321053.
2
Day-6 bone marrow aspirate for the prediction of response to remission induction therapy for acute myelogenous leukaemia.用于预测急性髓性白血病缓解诱导治疗反应的第6天骨髓穿刺物。
Blut. 1988 Aug;57(2):91-5. doi: 10.1007/BF00319732.
3
High-dose ara-C and etoposide in refractory or relapsing acute leukemia.大剂量阿糖胞苷和依托泊苷用于难治性或复发性急性白血病
Cancer Chemother Pharmacol. 1991;28(6):487-90. doi: 10.1007/BF00685829.